Android app Apple app link

AbCellera Biologics Inc (ABCL) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$3.13

$0.1 (-2.95%)
Last update: 10:04 AM EST
Day's range
$0
Day's range
$0

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/05/2024 BMO Capital Gary Nachman $5.00 $2.74   82.82%
08/23/2024 KeyBanc Scott Schoenhaus $5.00 $2.60   92.68%
05/07/2024 KeyBanc Scott Schoenhaus $7.00 $3.84   82.29%
12/14/2022 Goldman Sachs Andrea Tan $30.00 $10.13   196.15%

AbCellera Biologics Inc FAQ's

AbCellera Biologics Inc has been rated by research analysts at BMO Capital, KeyBanc, Leerink Partners, Goldman Sachs, Truist Financial, Credit Suisse in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.